Cargando…
Sirtuins: Promising Therapeutic Targets to Treat Ischemic Stroke
Stroke is a major cause of mortality and disability globally, with ischemic stroke (IS) accounting for over 80% of all stroke cases. The pathological process of IS involves numerous signal molecules, among which are the highly conserved nicotinamide adenine dinucleotide (NAD(+))-dependent enzymes kn...
Autores principales: | Liu, Yue, Wang, Liuding, Yang, Guang, Chi, Xiansu, Liang, Xiao, Zhang, Yunling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452362/ https://www.ncbi.nlm.nih.gov/pubmed/37627275 http://dx.doi.org/10.3390/biom13081210 |
Ejemplares similares
-
An overview of the evidence to guide decision-making in acupuncture therapies for early recovery after acute ischemic stroke
por: Wang, Liuding, et al.
Publicado: (2022) -
Post-stroke cognitive impairment and synaptic plasticity: A review about the mechanisms and Chinese herbal drugs strategies
por: Chi, Xiansu, et al.
Publicado: (2023) -
Efficacy and Safety of Xingnaojing Injection for Emergency Treatment of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
por: Wang, Liuding, et al.
Publicado: (2022) -
Research trends and hotspots of post-stroke cognitive impairment: a bibliometric analysis
por: Chi, Xiansu, et al.
Publicado: (2023) -
Will Sirtuins Be Promising Therapeutic Targets for TBI and Associated Neurodegenerative Diseases?
por: Yang, Qianjie, et al.
Publicado: (2020)